Leerink Partners Cut Price Target on Cardiovascular Systems (CSII) Following Disappointing 2Q and 3Q Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Needham & Company Downgrades Cardiovascular Systems (CSII) to Underperform
January 22, 2016 7:34 AM ESTNeedham & Company downgraded Cardiovascular Systems (NASDAQ: CSII) from Buy to Underperform, saying positive revenue growth may be a year away.
Analyst Mike Matson commented, "CSII's F2Q16 revenue missed and EPS beat consensus and management guided below consensus for F2Q16. We are... More
After-Hours Stock Movers 01/21: (EGHT) (XNPT) (MXIM) Higher; (CSII) (DGII) (SYRG) Lower (more...)
January 21, 2016 6:04 PM ESTCardiovascular Systems (NASDAQ: CSII) 20% LOWER; reported Q2 EPS of ($0.47), $0.03 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $41.4 million versus the consensus estimate of $44.82 million. GUIDANCE: Cardiovascular Systems sees Q3 2016 EPS of ($0.42)-($0.45), versus the consensus of ($0.45). Cardiovascular Systems sees Q3 2016 revenue of $40.5-42 million, versus the consensus of $45.8 million.
Digi Int'l (NASDAQ: DGII) 9% LOWER; reported Q1 EPS of $0.12, $0.05 better than the analyst estimate of $0.07. Revenue for the quarter came in at $50.3 million versus the... More
Cardiovascular Systems (CSII) Tops Q2 EPS by 3c, Offers Q3 Guidance
January 21, 2016 4:15 PM ESTCardiovascular Systems (NASDAQ: CSII) reported Q2 EPS of ($0.47), $0.03 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $41.4 million versus the consensus estimate of $44.82 million.
GUIDANCE:
Cardiovascular Systems sees Q3 2016 EPS of ($0.42)-($0.45), versus the consensus of ($0.45).... More
Trading Radar for 1/21: Verizon (VZ), AmEx (AXP), Starbucks (SBUX), Travelers (TRV), Schlumberger (SLB) Report
January 20, 2016 2:21 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
Earnings:
Alaska Air Group (NYSE: ALK) - consensus EPS $1.40
BB&T Corp. (NYSE: BBT) - consensus EPS $0.69
Bank of New York (NYSE: BK) - consensus EPS $0.64
BankUnited (NYSE:... More

